New Ways to Manage Celiac Disease
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
This project helps adults with celiac disease manage their gluten-free diet better using new technologies and telemedicine.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11117054 on NIH RePORTER |
What this research studies
Celiac disease can be challenging to manage, and sticking to a strict gluten-free diet is the only proven treatment. Many people don't get regular support from dietitians, and the disease can lead to serious health issues like anemia, infertility, and osteoporosis. This project explores how new tools, such as portable gluten sensors for food and urine tests, combined with virtual dietitian visits, can help you better understand and avoid gluten exposures. The goal is to make managing your diet easier and improve your overall health and quality of life.
Who could benefit from this research
Good fit: Ideal candidates are adults aged 21 and older who have celiac disease and are looking for new ways to manage their gluten-free diet.
Not a fit: Patients who do not have celiac disease or are not interested in using new technologies for diet management may not receive direct benefit from this particular approach.
Why it matters
Potential benefit: If successful, this approach could make it easier for people with celiac disease to follow their gluten-free diet, potentially reducing complications and improving their well-being.
How similar studies have performed: While the individual technologies have shown validity, this specific combination of novel gluten detection technologies with telemedicine for celiac disease management is being rigorously tested in this project.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Lebwohl, Benjamin — Columbia University Health Sciences
- Study coordinator: Lebwohl, Benjamin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.